<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01753492</url>
  </required_header>
  <id_info>
    <org_study_id>NL42312.068.12/METC12-2-073</org_study_id>
    <nct_id>NCT01753492</nct_id>
  </id_info>
  <brief_title>Trabeculectomy With Ologen</brief_title>
  <official_title>Trabeculectomy With Ologen-Pilot</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aeon Astron Europe B.V.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trabeculectomy is the gold standard procedure for the surgical treatment of glaucoma.
      Antimetabolites such as mitomycin-C (MMC)are widely used as an adjunctive during surgery to
      prevent scarring of the bleb. MMC has the risk for creating thin bleb walls, avascular blebs,
      and increased risk to infection, blebitis and endophthalmitis.

      Recently, a biodegradable porous collagen-glycosaminoglycan copolymer matrix implant
      (Ologen), has become available for glaucoma surgery.Although a few studies on filtering
      surgery with Ologen implantation have been performed, there is yet no conclusive evidence on
      effectivity and safety with Ologen implantation when compared to trabeculectomy with MMC.

      This is a prospective intervention pilot study to determine the degree of intraocular
      pressure (IOP) lowering of trabeculectomy with Ologen implantation in comparison to
      trabeculectomy with MMC. Additionally, the safety (per- and postoperative complications) of
      the two procedures will be compared.

      The study hypothesis is that trabeculectomy with Ologen will be a safer procedure than
      trabeculectomy with MMC, but probably at the cost of a less potent IOP lowering.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The results were disappointing.
  </why_stopped>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative intraocular pressure level</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of glaucoma medications</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>bleb aspect: hyperemia (grade 1, 2 or 3), bleb height (1, 2 or 3)</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>surgery time</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>complexity of surgical procedure</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>number of patients withdrawn from study because of failure</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Ologen implantation (single arm)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ologen implantation as an adjunctive to trabeculectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ologen</intervention_name>
    <arm_group_label>Ologen implantation (single arm)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary open-angle glaucoma with progression of visual field loss and/or uncontrolled
             intraocular pressure levels with medication.

          -  Indication for trabeculectomy with mitomycin-C

        Exclusion Criteria:

          -  Unability to discontinue oral anticoagulants

          -  Difficulty in reading or speaking Dutch

          -  Previous ocular surgery (cataract surgery allowed)

          -  Pregnant and breastfeeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Eye Clinic</name>
      <address>
        <city>Maastricht</city>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2012</study_first_submitted>
  <study_first_submitted_qc>December 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2012</study_first_posted>
  <last_update_submitted>May 22, 2015</last_update_submitted>
  <last_update_submitted_qc>May 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University Medical Center</investigator_affiliation>
    <investigator_full_name>Henny Beckers</investigator_full_name>
    <investigator_title>MD, PhD, Ophthalmologist</investigator_title>
  </responsible_party>
  <keyword>Intraocular pressure</keyword>
  <keyword>glaucoma</keyword>
  <keyword>trabeculectomy</keyword>
  <keyword>Ologen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

